$ISV - Breakout play for +10 to 30% Technical Analysis (TA)
The monthly and weekly was oversold and price pushed higher with significant momentum after a consolidation phase.
Retracement to $25 is expected However, the push to $30 would require catalysts to increase momentum.
We could hit $25 and then come back down or go through another consolidation phase before further upside to $30.
Price Target
Entry: $22-$23
Target 1: $25
Target 2: $30
Telus no follow thruTelus just released their earnings today and they were just as good as estimated but never the less the stock had no reaction and is now selling off.
The chart looks real ugly if you look at the Monthly and Quarterly window we have managed no follow thru after the big move down to start the year, the bulls are running out of time to step in and take this higher.
My target is $27.59 for the quarterly and monthly low once we break past that I think we take out last years low of $24.93
I am looking at september 16th expiry monthly calls strike at either 29/28 or 27
Novo - the best vaccine for your portfolio
The cost basis of the low power VLSI technician is highlighted in black. His mastery of concepts such as voltage, transistors, nanometers, electricity makes it no surprise he got in at the lows...
we will sell abve cb, -80%, but something tells me that the goldman man will be happy buying back, options at 33, will mature way in the green, as another opportunity once did present itself, at favourable prices today...
Breakthrough Discovery: AccuTOX Effectively Kills Cancer Cells by @newsfile on 2 Aug 2022, 03:15
Breakthrough Discovery: AccuTOX(TM) Effectively Kills Cancer Cells by Directly Eliciting DNA Damage
Vancouver, British Columbia--(Newsfile Corp. - August 2, 2022) - Defence Therapeutics Inc. (CSE: DTC) (FSE: DTC) (OTC Pink: DTCFF) ("Defence" or the "Company"), a Canadian biopharmaceutical company specialized in the development of immune-oncology vaccines and drug delivery technologies, is pleased to report the discovery of a novel DNA damaging function triggered by one of its lead compounds AccuTOXTM, which effectively elicits cell death in cancer cells.
Cancer can be generally described as a state of uncontrolled cell proliferation. This is mainly due to losses in the ability of a given cell to activate its own cell death via a specific set of proteins known to sense unusual activities. Although it is difficult to reactivate these specific pathways to elicit cancer cell death, AccuTOXTM can address this.
Defence previously reported (see press release of June 22, 2021) the discovery of an AccumTM variant, AccuTOXTM, capable of controlling cancer growth when injected directly in tumors. The use of AccuTOXTM in combination with multiple immune-checkpoints results in a survival rate between 60% and 100%, based on the pre-clinical tumor models studies in mice. The mode of action of AccuTOXTM approached is a non-biased transcriptomic application and revealed that the compound impairs several crucial pathways including DNA replication, cell division, nuclear integrity, and multiple modifications affecting DNA activity. The accumulation of exhaustive cell repair mechanisms triggered by AccuTOXTM combined to the build-up of misfolded proteins and generation of free radicals induce irreversible DNA damages leading to a general collapse in several cellular pathways resulting in effective cancer cell death.
"Defence's breakthrough discovery with its AccuTOXTM formulation as a novel potent small molecule capable of killing cancer cells is a significant advancement and development for oncology cancer treatment applications with AccumTM. Discovering that AccuTOXTM can behave as a chemotherapeutic agent targeting the DNA of cancer cells and an immune-checkpoint inhibitor booster is a new discovery that is highly valuable to Defence's pipeline and future potential developments. The AccuTOXTM presents a novel discovery as a platform for targeting multiple cancers. This novel discovery creates significant values and applications to our Antibody Drug Conjugate ("ADC") pipeline. Results are convincing that AccuTOXTM is the perfect potent small molecule to use in the development of our own ADC," says Mr. Plouffe, the CEO of Defence Therapeutics.
Defence is currently conducting GLP studies on AccuTOXTM prior to initiate a Phase I trial in North America.
SOY Sunopta Im just playing w layers for this chart. Im utilizing the pitchfan to focus on the channel within the linear regression I set up. I use this to set up for finding supports when it breaks. I have integrated a Fib Spiral to maintain the trade and to find the top resistance ranges on the run up. If you hover on the chart you will see additional patterns that I use to correlate exits when this fails
Tourmaline Oil - Beauty to Beast and Beast to BeautyTourmaline's pullback from it's $80 all time high and its bounce off the previous all time high is simply not deep enough, as evidenced by today's stop run over the June monthly close, which also produced one of those very credible "head and shoulders" patterns, on the back of the maniacs in the Natural Gas market running a monster short squeeze that ruined a lot of Q2s for "hedge funds."
WTI and NatGas are going to dump. Stocks are going to dump. It's not going to be a very pleasant period of time. But, natural gas and oil are something that the ruling regime cannot do without, because transportation and electricity rely entire upon them.
Oil is going to set a new all time high, and so is natural gas. They will do it at the same time, as the middle class is already experiencing maximum pain. This will give the central banks the handle they need to increasingly tighten, in addition to giving the Marxist-Leninist globalists a pretext to install social credit digital identification for the sake of fuel rationing.
Don't believe? Google Sri Lanka fuel rationing QR code & Ireland oil shortage war game.
Anyway, for Tourmaline, this Alberta gem is apt to give you a fine buying opportunity as commodities dump and the stock market crashes under $55 and $50. The target is simply $100+. With stops below the July 2021 highs of $35, you get an RR of 4.
Oil and natural gas, when they bounce, should be painfully brutal to bears. The situation should go parabolic, but it won't go all that high, and it won't go for all that long.
Think about what gold did when it set a new all time high, but faster, and for less time.
After the Party is over, the lights turn on and the music stops. Everyone will find a lot of vomit and trash to clean up, and it won't feel so fun and you won't feel so good with all that hangover and tab to pay, so make sure you sell your portfolio at the highs and buy your family something nice.
The best thing you can do is capitalize on your investment, put your wealth into something classical like gems, silver, gold, and prepare to return to tradition and prepare to cultivate yourselves.
Rogers Communication RCI.B - Weakness AheadI have been following Rogers Communication for a while watching price unfold as the company has been in the news over the last few months.
Firstly, Rogers would like to purchase Shaw communications which will constrict wireless competition landscape even further within Canada and secondly, they had a serious country wide outage a few weeks back which affected millions of their consumers as well as businesses such as Interac and emergency services. The outage revealed how vulnerable their infrastructure is to being affected as they appear to have less than reliable redundancy systems in place. Management noted they will be investing heavily into their infrastructure so this downtime issue will not happen again. Millions will be spend on their networks which will likely affect stock price.
Looking at the long term monthly timeframe, I see continued weakness in RCI.B after it breached an old Feb-2019 all time high of $73.82 but was strongly rejected with price currently sitting in the middle of the dealing range between $73.82 and $46.81.
Under current price, we have a few levels that I believe price will reach for.
1st target = 56.00
2nd target = 54.70
3rd target = 50.70
4th target = 46.80
Ultimate target for the stock in my opinion is $40.0. Feel free to comment on my idea. Feedback is always appreciated.
PELANGIO EXPLORATION!!!! JR MINER EXPLORER BUY OF THE YEAR!!!!PX is at .03 with a market cap of C$2.6M. Just the Obuasi property alone is worth at least $30M which is 10X the market cap. It is next door to Anglogold Ashanti Obuasi mine and they would snap it up at that price even with no further drilling. Plus they have other assets in Canada and Ghana. Ghana is a very mining friendly country because the government owns a percentage of mines, so they have a vested interest in the mining industry success.
Suncor - Pain to Pleasure and Pleasure to PainThe truth is that the energy sector has been doing really well. WTI Crude appeared to can't stop won't stop, and then Natural Gas appeared to can't stop won't stop.
Now, both NG1 and WTI are going to dump as the Federal Reserve points a nuclear bomb at the so-called "inflation," which in reality are high commodities and high stock prices.
Shortly it will appear that the Party is over for commodities and stocks, and this will provide a great deal of pain for people who have bought this pullback from $53, not realizing that the knife has yet to cut sufficiently deep.
However, natural gas and oil are something that the world cannot do without, for mankind is paralyzed without electricity, and no matter how much of a leftist you want to be and how much of the ESG Kool Aid you've drank, the cold truth is that without coal and natural gas you won't have electricity for your computers, and without oil, you won't have a shipping and transportation network.
A fundamental lack of either electricity or transport would threaten the ruling North American Communist Party's stability, and so they will be maintained, but the prices will drive ordinary people out of the market, and you will see social credit and digital identification-based fuel rationing during this time period, if all goes well for the Communist Party.
(It won't.)
In the process, WTI will set a new high, probably painfully higher than people expect, and in a faster time frame that people expect, but also coming up short of moonboy expectations. I would say that this $350/b as some have predicted is nonsense. I think the number is $180, and then demand destruction will be savagely en route.
For Natural Gas, I believe that Henry Hub futures are going to heatseek $18 after a solid clean out, and then the game will quickly wrap itself up. Look on the upside: at least you haven't been paying $40 like Europe and Australia already has for months.
All of this means that when everything is scary and prices have been driven deep enough to give you the chance to sell low after buying high, energy stocks will begin a real pump. This pump will serve as a bear trap and will be pretty amusing.
Your best bet on Suncor is in the $27 mark with a target above the double top around $62. Frankly, I would say you could see a new all time high over $80, but drawing this on this chart is too hard.
Either way with a $27 entry and a $62 target with a stop below $21, you're getting an RR of almost 5. An entry of $34.60 is more "realistic" for many people, so go for that, and just make sure you don't panic sell if terminal velocity continues on.
Make sure you sell it _all_ at the peaks and buy your family something nice. Remember: stocks won't buy you rice or gasoline. Cash. Is. King.
Independent research report with a 12-month price target of 0.67PlantX Receives Bullish Research Valuation from Capital Y Management
VANCOUVER, BC, July 27, 2022 /CNW/ - PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) ("PlantX" or the "Company") today announced that Capital Y Management, a New York-based hedge fund, has issued an independent research report on PlantX referring to PlantX as "a market leader with a disruptive business in an emerging industry with long term tailwinds''. Capital Y Management has established a 12-month price target of C$0.67 per common share, which would represent an enterprise value for PlantX of approximately C$68 million.
Hedge Fund Places PlantX Target Price at C$0.67 Per Share (CNW Group/PlantX Life Inc.)
"The PlantX team is hard at work to make plant-based diets available to everyone, expanding our presence in this rapidly growing market," said PlantX CEO, Lorne Rapkin. "We are encouraged that this independent report has recognized that we are well-positioned. While we are not commenting on the specific projections, we are focused on achieving success similar to Capital Y's outlook."
$IBO is emerging incalculably and investing its point$IBO is influencing auxiliary with fleetness on the TSX-V, as well as displaying a fantastic unit on the market, which was quite incredible!
universalibogaine inc Path Forward
Universal Ibogaine intends to acquire a network of addiction treatment clinics, licensing our treatment protocols to best in class treatment providers around the globe.
NuRAN Signs US $125 Million NaaS contract ($30M CAD market cap)NuRAN Signs US $125 Million NaaS Contract With MTN Sudan
- Minimum of 500 Sites in Sudan
- Contract Estimated at US $125 Million Agreement
- 10 Year Term to cover Rural Sudan
QUEBEC, QC / ACCESSWIRE / July 26, 2022 / NuRAN Wireless Inc. ("NuRAN Wireless") (CSE:NUR)(OTC PINK:NRRWF)(FSE:1RN), a leading supplier of mobile and broadband wireless infrastructure solutions, is pleased to announce the signing of a definitive 10 year Network As A Service ("NaaS") contract with MTN Sudan Company Ltd. for the deployment of rural mobile infrastructure in Sudan.
The 10-year agreement is estimated to represent up to approximately US $125 Million in revenues over the course of the contract assuming that the 500 estimated sites are completed. The estimated revenues are subject to associated project expenses including expenses associated with satellite bandwidth, site lease, network operations center expenses, curative and preventative maintenance fees, project management and monitoring fees, and insurance. Fees for the NaaS services provided by NuRAN under the agreement are paid on a revenue sharing basis. The project will support 2G and 3G with variety of site categories to cover different population densities and coverage areas. NuRAN expects to retain the ownership of the infrastructure after completion of the contract which increases the value of the agreement.
"This is another important milestone for NuRAN as we press ahead to our stated goal of having 10,000 sites under contract. This contract also further solidifies our growing relationship with MTN as a key partner in bringing mobile connectivity to the people that need it the most. Mobile connectivity is a life blood to these communities and NuRAN is extremely proud to be at the center of bridging this important gap" stated Francis Letourneau, CEO at NuRAN Wireless Inc.
Following recently announced agreements with MTN South Sudan and Namibia, this agreement with another subsidiary of MTN is intended to continue to build on NuRAN's NaaS expansion in Africa and expand the Company's relationship with MTN. NuRAN now has 3,192 sites in 5 countries throughout Africa under contract in pursuit of its overall objective of 10,000 sites under contract.
Pursuant to the terms of the contract, the parties intend to install a minimum of 500 rural networking sites in Sudan. The number of sites may be increased and will fluctuate as the project is under way subject to factors such as penetration rate, ARPU (average revenue per user) and network charges to be further refined, provided that the project will be subject to a minimum number of 500 sites over the 10-year term of the agreement.
The NuRAN NaaS model facilitates network expansion for mobile operators by managing and controlling the build, operation, and maintenance of cellular sites along with associated capital expenditures. The sites are then monetized by providing connectivity on a paid for service basis. Leveraging its carrier-grade mobile network infrastructure solutions as well as its extensive expertise in the building of cost-effective cellular infrastructure, NuRAN is able to establish network operations from the ground up with an exceptional return on investment. While deployments under the NaaS model require the Company to make upfront investments, they generate significant value whereby NuRAN benefits from long-term recurring revenues with compelling returns. The Company intends to fund such deployments mostly through asset-based project financing or similar debt-oriented facilities. Such financing options and sources are being investigated with a view to carrying out deployments in the most efficient manner.
easy money dollaramaThe Canadian dollar has started to increase and it seemed it has a long way to go. Dollarama is one of the vital veins of the Canadian economy and the minor recovery in the economy would change this stock to a skyrocket!
% 4-5 is the easiest target for now, but in my humble opinion, $100 is not so far from today.
$IBO a stock bloating with a massive share count on the TSX-V A billion stock trading for mere pennies in the market, I bought this highly exclusive stock $IBO a week ago and always had a satisfying experience ever since.
Parallel channel for the short term.I've used a parallel channel to try and see if we stay within this range. It appears to be bullish for now, I'd like to see us stay within it for another week. Though HUT sometimes has some rapid moves.
First chart ever, is this meaningful at all?I'm trying to learn how to find meaningful points on a chart. I figured I'd pick one of my losing trades in the past and hopefully make it profitable in the future. Any input on my points of intersection and general trend lines would be helpful.
WPRT Daily TimeFrame Analysis (ID 1)✳️Position ID: 1
📈Stock: WPRT
🏦Exchange: TSX
⚖️Leverage: 0% (x:x)
💰Price: 1.45$
🔥Quantity: 50
🐃Position: Long
⏱Duration: 6 months to 5 years
💥Upside: 160.00% at 3.77$
*Info based of Q1 2022
I do not provide personal investment advice and I am not a qualified licensed investment advisor. I am an amateur investor.
All information found here, including any ideas, opinions, views, predictions, forecasts, commentaries, suggestions, or stock picks, expressed or implied herein, are for informational, entertainment or educational purposes only and should not be construed as personal investment advice. While the information provided is believed to be accurate, it may include errors or inaccuracies.
I will not and cannot be held liable for any actions you take as a result of anything you read here.
Conduct your own due diligence, or consult a licensed financial advisor or broker before making any and all investment decisions. Any investments, trades, speculations, or decisions made on the basis of any information found on this site, expressed or implied herein, are committed at your own risk, financial or otherwise.
I reflects my own views, ideas and opinions. It is not a production of my employer, nor is it affiliated with any broker/dealer or registered investment advisor.
No representations or warranties are made with respect to the accuracy or completeness of the content of this entire weblog, including any links to other sites. The links provided are maintained by their respective organizations and they are solely responsible for their content. All information presented here is provided ‘as is’, without warranty of any kind, expressed or implied.
From time to time I may include affiliate links and advertisements that result in my receiving a payment should a visitor click on a link or sign up to a service, as per established Internet practice. Readers are entirely responsible for any actions they take as a result of reading or clicking on links on the site, and are urged to read the small print!
Bearish market is changing the rulesIt seems like all trading rules are out of control in this bearish market. One of the Greatest investors of all time Warren Buffett said "be greedy when others are fearful; and be fearful when others are Greedy" this rings true in the mind. However Buffer was an investor & not a traders. the rules differ or both games.
THIS IS ONE OF MY BEST & MOST PROFITABLE trades.
short term (W) is in correction while longterm (M) still technically in uptrend. price comes into the DZ which is the HL (Higher Low) of the
longterm (M) chart. provide low risk entry & high profit.
It seems in this market nothing hold true. As the price broke through the DZ. I followed my rules and took the Loss.
If there is a lesson to carry. the DZ was tested (in the dark square) this basically weakens the
DZ. One of my first trading teacher compared a DZ to a door. the more you knock on the door the more likely it will break down. This DZ door has been knocked before. it broke & the door opened. A better trade enhancer would of been a fresh untested DZ
CPG - bullish entry pattern, medium riskIf it holds 10 days EMA level. Upcoming earnings risk is offset by: it held very strong support and formed a bollinger band top. I think it will be up post earnings, up to the upper band
$IBO announced a vital addition of clinical trials director
Julie Dumouchel has been named Director of Clinical Trials at UI, which is a significant strategic move. Julie Dumouchel has 25 years of experience in the pharmaceutical sector, where she has worked in a variety of clinical research jobs and has a thorough grasp of the drug development process.
$IBO propagating effortlessly, investors under the clutch
$IBO has exceptional potential when it comes to volatility, and the share prices have been hiking lately, last closing of the stock trading at $0.0400 on TSX-V with a noted spike
